Found 15531 matches for
Baricitinib – an anti-inflammatory treatment for rheumatoid arthritis– is being investigated in the RECOVERY trial, the world’s largest clinical trial of treatments for patients hospitalised with COVID-19, taking place in 177 hospital sites across the UK and with over 33,000 patients recruited so far. As an anti-inflammatory, baricitinib may block the signalling activity of cytokine molecules which contribute to the hyper-inflammatory state seen in severe COVID-19. It is thought that baricitinib may act also have some anti-viral activity. The other treatments currently being investigated in the RECOVERY trial are Regeneron’s antibody cocktail, Aspirin and Colchicine.
The MSc in Modelling for Global Health is a full-time one-year taught programme that provides interdisciplinary content on modelling, health evidence to inform the modelling, and policy processes to inform decisions. Week-long modules are delivered through a mix of interactive practical sessions and lectures in person at Oxford. Demand for a skilled workforce in this field is on the rise and there is great potential for mathematical and economic modelling to help guide policy for national health systems and international policymaking.
Public Engagement with Research is a two-way process that aims to benefit both the public and researchers, and ultimately enhance the quality or impact of research. Members of the public can be involved in many ways, in the design, conduct and dissemination of research. Activities can take different forms, to inform and inspire, consult and listen, or collaborate with the public.